Therapeutic proteins are more complex and sensitive compared to synthetic small molecule drugs, requiring strict control over product stability due to factors like temperature, pH, and interfaces. Changes in protein structure (e.g., aggregates), which can affect safety and efficacy, are classified as critical quality attributes (CQAs). Protein aggregates are particularly critical, as they can trigger immune reactions. Typically, after production, the drug substance (DS) is stored in large containers at low temperatures to extend shelf life and reduce the risk of microbial contamination and transport stress. However, freeze-thaw (F/T) processes can lead to protein instability. These instabilities arise from stress factors like cryo-concentration, surface stress from ice crystals, and air bubbles during freezing. Especially at large scales, cryo-concentration can cause inhomogeneous solute distribution, destabilizing the protein due to changes in the buffer-to-protein ratio. Additionally, crystallization of buffer components can alter pH. Ice crystals and air bubbles provide surfaces that can destabilize proteins. Process factors such as container type and freezer impact F/T rates, which are essential process parameters. Controlled and reproducible F/T processes are critical for ensuring consistent product quality. The F/T process in drug substance vials is particularly challenging to control because conventional freezers are typically used, as specialized F/T systems are only available for DS bags. Since F/T processes are scale-dependent, process characterization is key, though experimental methods for this are not standardized. This study aimed to (1) establish experimental methods for characterizing F/T processes in DS bottles and (2) investigate a novel F/T device that could improve the F/T process in DS bottles. Using a surrogate solution, methods for process characterization in bottles were first established, including time-resolved temperature measurements and sampling methods to examine concentration gradients after freezing (cryo-concentration) and thawing. A sampling method developed for cryo-concentration determination using ice core drilling allowed for efficient and sensitive measurement, unlike conventional methods. The novel F/T device, which operates in conventional freezers, could be a cost-effective alternative to improve passive F/T processes. The device consists of a polystyrene casing and a fan that generates a bottom-up airflow, resulting in a different F/T geometry compared to passive freezing and thawing. This device led to faster freezing with reduced cryo-concentration, but only in an empty freezer. In a fully loaded freezer, the process time was longer, with increased cryo-concentration. These results highlight the need for high freezing speed to minimize cryo-concentration and suggest that directional freezing improves homogeneity only with adequate freezing speed. The device's insulated lid reduced ice mound formation, minimizing pressure-related damage during freezing. Thawing with the device resulted in faster thawing without significantly affecting concentration gradients. Thawing time in a water bath was still considerably shorter. In conclusion, the F/T device offers advantages in faster thawing times. However, for a reproducible process, high-performance freezers are likely required, as using the device in freezers with limited cooling capacity negatively impacted the process.